511 related articles for article (PubMed ID: 10359535)
41. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
42. Mutated p21(WAF1/CIP1/SDI1) lacking CDK-inhibitory activity fails to prevent apoptosis in human colorectal carcinoma cells.
Lu Y; Yamagishi N; Yagi T; Takebe H
Oncogene; 1998 Feb; 16(6):705-12. PubMed ID: 9488034
[TBL] [Abstract][Full Text] [Related]
43. Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 melanoma terminal differentiation.
Rieber M; Rieber MS
Cell Growth Differ; 1994 Dec; 5(12):1339-46. PubMed ID: 7696182
[TBL] [Abstract][Full Text] [Related]
44. Immortalization of human fibroblasts by SV40 large T antigen results in the reduction of cyclin D1 expression and subunit association with proliferating cell nuclear antigen and Waf1.
Peterson SR; Gadbois DM; Bradbury EM; Kraemer PM
Cancer Res; 1995 Oct; 55(20):4651-7. PubMed ID: 7553644
[TBL] [Abstract][Full Text] [Related]
45. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity.
Ruesch MN; Laimins LA
J Virol; 1997 Jul; 71(7):5570-8. PubMed ID: 9188631
[TBL] [Abstract][Full Text] [Related]
46. Transforming growth factor-beta 1 stimulates or inhibits cell growth via down- or up-regulation of p21/Waf1.
Miyazaki M; Ohashi R; Tsuji T; Mihara K; Gohda E; Namba M
Biochem Biophys Res Commun; 1998 May; 246(3):873-80. PubMed ID: 9618305
[TBL] [Abstract][Full Text] [Related]
47. Expression of a novel form of p21Cip1/Waf1 in UV-irradiated and transformed cells.
Poon RY; Hunter T
Oncogene; 1998 Mar; 16(10):1333-43. PubMed ID: 9546435
[TBL] [Abstract][Full Text] [Related]
48. p53-independent increase in p21WAF1 and reciprocal down-regulation of cyclin A and proliferating cell nuclear antigen in bromodeoxyuridine-mediated growth arrest of human melanoma cells.
Strasberg Rieber M; Welch DR; Miele ME; Rieber M
Cell Growth Differ; 1996 Feb; 7(2):197-202. PubMed ID: 8822203
[TBL] [Abstract][Full Text] [Related]
49. A mutant E2F-1 transcription factor that affects the phenotype of NIH3T3 fibroblasts inefficiency associates with cyclin A-cdk2.
Jordan-Sciutto KL; Hall DJ
Biochem Cell Biol; 1998; 76(1):37-44. PubMed ID: 9666304
[TBL] [Abstract][Full Text] [Related]
50. The C-terminal region of p21SDI1/WAF1/CIP1 is involved in proliferating cell nuclear antigen binding but does not appear to be required for growth inhibition.
Nakanishi M; Robetorye RS; Pereira-Smith OM; Smith JR
J Biol Chem; 1995 Jul; 270(29):17060-3. PubMed ID: 7615495
[TBL] [Abstract][Full Text] [Related]
51. Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide.
Ma Y; Prigent SA; Born TL; Monell CR; Feramisco JR; Bertolaet BL
Cancer Res; 1999 Oct; 59(20):5341-8. PubMed ID: 10537318
[TBL] [Abstract][Full Text] [Related]
52. Inhibition of E2F activity by the cyclin-dependent protein kinase inhibitor p21 in cells expressing or lacking a functional retinoblastoma protein.
Dimri GP; Nakanishi M; Desprez PY; Smith JR; Campisi J
Mol Cell Biol; 1996 Jun; 16(6):2987-97. PubMed ID: 8649410
[TBL] [Abstract][Full Text] [Related]
53. Negative regulation of cell growth and differentiation by TSG101 through association with p21(Cip1/WAF1).
Oh H; Mammucari C; Nenci A; Cabodi S; Cohen SN; Dotto GP
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5430-5. PubMed ID: 11943869
[TBL] [Abstract][Full Text] [Related]
54. Ras promotes p21(Waf1/Cip1) protein stability via a cyclin D1-imposed block in proteasome-mediated degradation.
Coleman ML; Marshall CJ; Olson MF
EMBO J; 2003 May; 22(9):2036-46. PubMed ID: 12727871
[TBL] [Abstract][Full Text] [Related]
55. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells.
Oh M; Choi YH; Choi S; Chung H; Kim K; Kim SI; Kim DK; Kim ND
Int J Oncol; 1999 May; 14(5):869-75. PubMed ID: 10200336
[TBL] [Abstract][Full Text] [Related]
56. p21 Disrupts the interaction between cdk2 and the E2F-p130 complex.
Shiyanov P; Bagchi S; Adami G; Kokontis J; Hay N; Arroyo M; Morozov A; Raychaudhuri P
Mol Cell Biol; 1996 Mar; 16(3):737-44. PubMed ID: 8622674
[TBL] [Abstract][Full Text] [Related]
57. Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F.
Guo K; Walsh K
J Biol Chem; 1997 Jan; 272(2):791-7. PubMed ID: 8995365
[TBL] [Abstract][Full Text] [Related]
58. Transformation by v-Jun prevents cell cycle exit and promotes apoptosis in the absence of serum growth factors.
Clark W; Gillespie DA
Cell Growth Differ; 1997 Apr; 8(4):371-80. PubMed ID: 9101083
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of CDK activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein.
Funk JO; Waga S; Harry JB; Espling E; Stillman B; Galloway DA
Genes Dev; 1997 Aug; 11(16):2090-100. PubMed ID: 9284048
[TBL] [Abstract][Full Text] [Related]
60. Separate domains of p21 involved in the inhibition of Cdk kinase and PCNA.
Chen J; Jackson PK; Kirschner MW; Dutta A
Nature; 1995 Mar; 374(6520):386-8. PubMed ID: 7885482
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
